Edward Tenthoff

Why Moderna Shares Are Rebounding From Friday's Losses

Moderna Puts Its First Seasonal Flu Vaccine In The Clinic

Moderna Analyst Says Biotech Has 'First-To-Market' Potential For Coronavirus Vaccine

Moderna Puts Its First Seasonal Flu Vaccine In The Clinic

Moderna Analyst Says Biotech Has 'First-To-Market' Potential For Coronavirus Vaccine

Analysts React To Arrowhead's Janssen Collaboration: Downside In Stock May Be 'Misguided'

PiperJaffray, Stifel Defend Array Biopharma As Stock Falls On Profit-Taking

Analysts React To Arrowhead's Janssen Collaboration: Downside In Stock May Be 'Misguided'

|

PiperJaffray, Stifel Defend Array Biopharma As Stock Falls On Profit-Taking

|

Why Investors Should Take Another Look At Alnylam Pharmaceuticals

|

The Search For Silver Linings In The Cloud Of Negative Novavax News

|